http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115137314-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c066e99a149d78d63a4db1751997568
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-0025
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e605d694aca59f773b8779ba224bfe37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2748194bbd33dd51c3f4f872d1bb8314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1780c2afa1e87826848cb391b27e7874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_206b8dcae608da6c2976c453f3e127cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a214f383dc51b3aae0d2e2cdffa5d2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9edc71dcee8edef82cde46f690bdf69c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60eec66ef76c8b50bcc38f28a8d8ed2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7225a1b5ad20f001b1b9830b63ea10c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e35e565cd47b9308eff9839294ecafe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2071476d0184aa1df84d7112320bb8
publicationDate 2022-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-115137314-A
titleOfInvention Myopia risk assessment method, device and wearable device
abstract The present disclosure relates to the technical field of myopia risk assessment, and provides a myopia risk assessment method, device and wearable device. The method includes: acquiring ambient light intensity data, body hormone data and sympathetic nerve excitability data at the current time; inputting the ambient light intensity data, body hormone data and sympathetic nerve excitability data into a pre-trained myopia risk assessment model to obtain myopia risk The evaluation result, wherein the myopia risk evaluation model is obtained by training based on the ambient light intensity data, the body hormone data and the sympathetic nerve excitability data corresponding to the known myopia risk. The embodiments of the present disclosure can realize the external environment characterization of hormone secretion time by collecting and processing ambient light intensity data, bodily hormone data (such as melatonin and/or dopamine) and sympathetic nerve excitability data, and then to the bodily hormone data. Comprehensive monitoring (eg, melatonin and/or dopamine) greatly increases the accuracy of predicting myopia risk.
priorityDate 2022-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017319383-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507128

Total number of triples: 35.